Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Dengue virus NS1 enhances viral replication and pro-inflammatory cytokine production in human dendritic cells.

Alayli F, Scholle F.

Virology. 2016 Sep;496:227-36. doi: 10.1016/j.virol.2016.06.008. Epub 2016 Jun 24.

PMID:
27348054
2.

The adaptor molecule Trif contributes to murine host defense during Leptospiral infection.

Jayaraman PA, Devlin AA, Miller JC, Scholle F.

Immunobiology. 2016 Sep;221(9):964-74. doi: 10.1016/j.imbio.2016.05.006. Epub 2016 May 24.

PMID:
27259371
3.

Photosensitizer-Embedded Polyacrylonitrile Nanofibers as Antimicrobial Non-Woven Textile.

Stanley SL, Scholle F, Zhu J, Lu Y, Zhang X, Situ X, Ghiladi RA.

Nanomaterials (Basel). 2016 Apr 20;6(4). pii: E77. doi: 10.3390/nano6040077.

4.

Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1β Secretion: A Primary Human Monocyte Model.

Callaway JB, Smith SA, Widman DG, McKinnon KP, Scholle F, Sempowski GD, Dittmer DP, Crowe JE Jr, de Silva AM, Ting JP.

PLoS One. 2015 Aug 24;10(8):e0136708. doi: 10.1371/journal.pone.0136708. eCollection 2015.

5.

Synthesis, Characterization, and Antimicrobial Efficacy of Photomicrobicidal Cellulose Paper.

Carpenter BL, Scholle F, Sadeghifar H, Francis AJ, Boltersdorf J, Weare WW, Argyropoulos DS, Maggard PA, Ghiladi RA.

Biomacromolecules. 2015 Aug 10;16(8):2482-92. doi: 10.1021/acs.biomac.5b00758. Epub 2015 Jul 30.

PMID:
26181636
6.

Antiviral, Antifungal and Antibacterial Activities of a BODIPY-Based Photosensitizer.

Carpenter BL, Situ X, Scholle F, Bartelmess J, Weare WW, Ghiladi RA.

Molecules. 2015 Jun 8;20(6):10604-21. doi: 10.3390/molecules200610604.

7.

Modulation of innate immune signaling by the secreted form of the West Nile virus NS1 glycoprotein.

Crook KR, Miller-Kittrell M, Morrison CR, Scholle F.

Virology. 2014 Jun;458-459:172-82. doi: 10.1016/j.virol.2014.04.036. Epub 2014 May 14.

8.

Abrogation of TLR3 inhibition by discrete amino acid changes in the C-terminal half of the West Nile virus NS1 protein.

Morrison CR, Scholle F.

Virology. 2014 May;456-457:96-107. doi: 10.1016/j.virol.2014.03.017. Epub 2014 Apr 3.

9.

Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs.

Bogerd HP, Skalsky RL, Kennedy EM, Furuse Y, Whisnant AW, Flores O, Schultz KL, Putnam N, Barrows NJ, Sherry B, Scholle F, Garcia-Blanco MA, Griffin DE, Cullen BR.

J Virol. 2014 Jul;88(14):8065-76. doi: 10.1128/JVI.00985-14. Epub 2014 May 7.

10.

Anetumab ravtansine: a novel mesothelin-targeting antibody-drug conjugate cures tumors with heterogeneous target expression favored by bystander effect.

Golfier S, Kopitz C, Kahnert A, Heisler I, Schatz CA, Stelte-Ludwig B, Mayer-Bartschmid A, Unterschemmann K, Bruder S, Linden L, Harrenga A, Hauff P, Scholle FD, Müller-Tiemann B, Kreft B, Ziegelbauer K.

Mol Cancer Ther. 2014 Jun;13(6):1537-48. doi: 10.1158/1535-7163.MCT-13-0926. Epub 2014 Apr 8.

11.

Dynamic gadobutrol-enhanced MRI predicts early response to antivascular but not to antiproliferation therapy in a mouse xenograft model.

Dassler K, Scholle FD, Schütz G.

Magn Reson Med. 2014 May;71(5):1826-33. doi: 10.1002/mrm.24815. Epub 2013 Jun 10.

PMID:
23754607
12.

Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling.

Winkelmann ER, Widman DG, Xia J, Ishikawa T, Miller-Kittrell M, Nelson MH, Bourne N, Scholle F, Mason PW, Milligan GN.

Vaccine. 2012 Feb 14;30(8):1465-75. doi: 10.1016/j.vaccine.2011.12.103. Epub 2012 Jan 5.

13.
14.

Identification of microRNAs expressed in two mosquito vectors, Aedes albopictus and Culex quinquefasciatus.

Skalsky RL, Vanlandingham DL, Scholle F, Higgs S, Cullen BR.

BMC Genomics. 2010 Feb 18;11:119. doi: 10.1186/1471-2164-11-119.

15.

Terameprocol, a methylated derivative of nordihydroguaiaretic acid, inhibits production of prostaglandins and several key inflammatory cytokines and chemokines.

Eads D, Hansen R, Oyegunwa A, Cecil C, Culver C, Scholle F, Petty I, Laster S.

J Inflamm (Lond). 2009 Jan 8;6:2. doi: 10.1186/1476-9255-6-2.

16.

Monitoring therapeutical intervention with ezetimibe using targeted near-infrared fluorescence imaging in experimental atherosclerosis.

Graf K, Dietrich T, Tachezy M, Scholle FD, Licha K, Stawowy P, Grafe M, Hauff P, Fleck E.

Mol Imaging. 2008 Mar-Apr;7(2):68-76.

PMID:
18706289
17.

West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction.

Wilson JR, de Sessions PF, Leon MA, Scholle F.

J Virol. 2008 Sep;82(17):8262-71. doi: 10.1128/JVI.00226-08. Epub 2008 Jun 18.

18.

Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production.

Bourne N, Scholle F, Silva MC, Rossi SL, Dewsbury N, Judy B, De Aguiar JB, Leon MA, Estes DM, Fayzulin R, Mason PW.

J Virol. 2007 Sep;81(17):9100-8. Epub 2007 Jun 13.

19.

Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines.

Fayzulin R, Scholle F, Petrakova O, Frolov I, Mason PW.

Virology. 2006 Jul 20;351(1):196-209. Epub 2006 May 2.

20.

The in vitro stability of air-filled polybutylcyanoacrylate microparticles.

Olbrich C, Hauff P, Scholle F, Schmidt W, Bakowsky U, Briel A, Schirner M.

Biomaterials. 2006 Jul;27(19):3549-59. Epub 2006 Mar 14.

PMID:
16537092

Supplemental Content

Loading ...
Support Center